CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L901. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $401,100 | -73.9% | 95,500 | -62.7% | 0.00% | -75.0% |
| Q4 2022 | $1,538,560 | +42.2% | 256,000 | +37.7% | 0.00% | +100.0% |
| Q3 2022 | $1,082,000 | -30.7% | 185,900 | -28.9% | 0.00% | 0.0% |
| Q2 2022 | $1,561,000 | +218.6% | 261,500 | +149.0% | 0.00% | – |
| Q1 2022 | $490,000 | +61.2% | 105,000 | -14.3% | 0.00% | – |
| Q4 2021 | $304,000 | +186.8% | 122,500 | +242.2% | 0.00% | – |
| Q3 2021 | $106,000 | -67.7% | 35,800 | -72.7% | 0.00% | – |
| Q2 2021 | $328,000 | +1461.9% | 131,200 | +1697.3% | 0.00% | – |
| Q1 2021 | $21,000 | +10.5% | 7,300 | +25.9% | 0.00% | – |
| Q4 2020 | $19,000 | +35.7% | 5,800 | -13.4% | 0.00% | – |
| Q3 2020 | $14,000 | +133.3% | 6,700 | +34.0% | 0.00% | – |
| Q2 2020 | $6,000 | -68.4% | 5,000 | -76.2% | 0.00% | – |
| Q1 2020 | $19,000 | -40.6% | 21,000 | +5.0% | 0.00% | – |
| Q4 2019 | $32,000 | +113.3% | 20,000 | +33.3% | 0.00% | – |
| Q1 2019 | $15,000 | -75.8% | 15,000 | +21.0% | 0.00% | -100.0% |
| Q2 2018 | $62,000 | -33.3% | 12,400 | -47.9% | 0.00% | 0.0% |
| Q1 2018 | $93,000 | +3000.0% | 23,800 | +2875.0% | 0.00% | – |
| Q3 2017 | $3,000 | -87.5% | 800 | -89.2% | 0.00% | – |
| Q2 2017 | $24,000 | – | 7,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 5,800 | $19,000 | 0.00% |
| SIMPLEX TRADING, LLC | 60 | $0 | 0.00% |